Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

MicroRNAs01:22

MicroRNAs

22.2K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
22.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nanoparticle-Based Antigen Delivery: Advancing Immunization Strategies against Infectious Pathogens.

Biomaterials research·2026
Same author

Multitalented Hybrid Targeted Nanoconstructs Selectively Repress Survival Genes and Induce Breast Tumor Regression In Vivo.

Advanced healthcare materials·2026
Same author

Identification of flavonoids in the endemic taxa <i>Haplanthodes verticillata</i>, <i>Haplanthodes plumosa</i>, <i>Haplanthodes tentaculata</i>, <i>Haplanthodes neilgherryensis</i> and <i>Haplanthodes neilgherryensis</i> var. <i>toranganensis</i> by liquid chromatography quadrupole time of flight mass spectrometry.

Natural product research·2025
Same author

Synthetic Epoxy-Phenanthridine-Triazole Conjugates Induce Dual Redox Imbalance and Metabolic Remodeling in Breast Cancer Cells: An Integrative Mechanistic Evaluation from Synthesis to Mitochondrial Collapse.

ACS omega·2025
Same author

Updated Classification of Skin Substitutes.

Indian journal of plastic surgery : official publication of the Association of Plastic Surgeons of India·2023
Same author

Bi<sub>2</sub>Te<sub>2</sub>Se and Sb<sub>2</sub>Te<sub>3</sub> heterostructure based photodetectors with high responsivity and broadband photoresponse: experimental and theoretical analysis.

Physical chemistry chemical physics : PCCP·2023

Related Experiment Video

Updated: Oct 10, 2025

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
04:41

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease

Published on: July 3, 2018

8.3K

MicroRNAs: A Neoteric Approach to Understand Pathogenesis, Diagnose, and Treat Myocardial Infarction.

Nida Irfan Sayed-Pathan1,2, Pramod Kumar1,2, Kishore M Paknikar1,2

  • 1Nanobioscience Group, Agharkar Research Institute, Pune, India; and.

Journal of Cardiovascular Pharmacology
|December 9, 2021
PubMed
Summary

MicroRNAs (miRNAs) are key regulators of heart repair after myocardial infarction. Targeting these molecules in cardiomyocytes offers a promising therapeutic strategy to improve cardiac function and regeneration post-heart attack.

More Related Videos

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
09:53

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

Published on: June 15, 2018

7.6K
Preparation of a Non-Cardiomyocyte Cell Suspension for Single-Cell RNA Sequencing from a Post-Myocardial Infarction Adult Mouse Heart
05:54

Preparation of a Non-Cardiomyocyte Cell Suspension for Single-Cell RNA Sequencing from a Post-Myocardial Infarction Adult Mouse Heart

Published on: February 3, 2023

2.3K

Related Experiment Videos

Last Updated: Oct 10, 2025

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
04:41

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease

Published on: July 3, 2018

8.3K
In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
09:53

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

Published on: June 15, 2018

7.6K
Preparation of a Non-Cardiomyocyte Cell Suspension for Single-Cell RNA Sequencing from a Post-Myocardial Infarction Adult Mouse Heart
05:54

Preparation of a Non-Cardiomyocyte Cell Suspension for Single-Cell RNA Sequencing from a Post-Myocardial Infarction Adult Mouse Heart

Published on: February 3, 2023

2.3K

Area of Science:

  • Cardiovascular Science
  • Molecular Biology
  • Regenerative Medicine

Background:

  • Myocardial infarction (MI) is a leading cause of global mortality from ischemic heart disease.
  • Post-MI cardiac dysfunction involves cardiomyocyte damage, leading to adverse remodeling like hypertrophy and fibrosis.
  • MicroRNAs (miRNAs) are critical regulators of cellular processes, including cardiomyocyte survival and regeneration.

Purpose of the Study:

  • To review the role of specific miRNAs in cardiomyocyte repair and regeneration following myocardial infarction.
  • To explore the therapeutic potential of targeting miRNAs for reversing adverse cardiac remodeling post-MI.

Main Methods:

  • Literature review of studies investigating miRNA function in cardiac repair.
  • Analysis of miRNA expression patterns in post-myocardial infarction models.
  • Synthesis of current knowledge on miRNA-mediated pathways in cardiomyocytes.

Main Results:

  • Specific miRNAs significantly influence cardiomyocyte survival, proliferation, and differentiation.
  • Dysregulated miRNA expression is linked to pathological cardiac remodeling post-MI.
  • miRNA-based therapies show potential in preclinical models to restore cardiac function.

Conclusions:

  • MicroRNAs are crucial players in the complex processes of cardiac repair and regeneration post-MI.
  • Targeting specific miRNAs presents a viable therapeutic avenue for treating heart disease.
  • Further research into miRNA therapeutics could lead to novel treatments for myocardial infarction patients.